A. Soglian

1.2k citations
6 papers · 909 indexed · 1 hit paper · h-index 5

Impact in

    • Venous Thromboembolism Diagnosis and Management
    • Atrial Fibrillation Management and Outcomes
    • Antiplatelet Therapy and Cardiovascular Diseases
    • Acute Myocardial Infarction Research
    • Cardiac Arrhythmias and Treatments

Papers in

A. Soglian

5 papers receiving 869 citations

Hit Papers

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial 2008 · 807 citations
8072008202620142020250500750

Peers

A. Soglian
Comparison fields: 5 of 66
  • Internal Medicine 740
  • Cardiology and Cardiovascular Medicine 719
  • Hematology 82
  • Neurology 50
  • Surgery 175
Replace Karin Hermansson with:
Karin Hermansson Sweden
Herbert Noack Germany
Anders Nissen Bonde Denmark
Giorgio Mattioli Italy
Petr Janský Czechia
Stuart Abramson United States
Martin N. Vicenzi United States
Alpay Arıbaş Türkiye
Deborah Bergman United States
Fiona E. Ralley Canada
A. Soglian relative to Karin Hermansson Sweden Karin Hermansson's profile →
Citations per field
00.5×1.7×
Karin Hermansson · 1×
Citations per year

Countries citing papers authored by A. Soglian

Since Specialization
Citations

This map shows the geographic impact of A. Soglian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Soglian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Soglian more than expected).

Fields of papers citing papers by A. Soglian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Soglian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Soglian. The network helps show where A. Soglian may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Soglian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Soglian Line = papers co-authored together A. Soglian links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1 20250
2
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
Hit paper breakdown →
2008807
3 200710
4 200576
5 20027
6 20009

About A. Soglian

A. Soglian is a scholar working on Internal Medicine, Gastroenterology, Endocrine and Autonomic Systems, Neurology and Endocrinology, Diabetes and Metabolism, having authored 6 papers that have together received 909 indexed citations. Recurring topics across this work include Gastroesophageal reflux and treatments (1 paper), Neurological Disease Mechanisms and Treatments (1 paper), Pituitary Gland Disorders and Treatments (1 paper), Intestinal Malrotation and Obstruction Disorders (1 paper), Acute Ischemic Stroke Management (1 paper), Growth Hormone and Insulin-like Growth Factors (1 paper), Diabetes Treatment and Management (1 paper) and Receptor Mechanisms and Signaling (1 paper). The work is most often cited by research in Internal Medicine (740 citations), Cardiology and Cardiovascular Medicine (719 citations), Hematology (82 citations), Neurology (50 citations) and Surgery (175 citations). A. Soglian has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Patrick Mouret, Sylvia Haas, Frank Misselwitz, Ajay K. Kakkar, Ákos F. Pap, Benjamin Brenner, Bengt I. Eriksson, Ola E. Dahl, Leonardo Pantoni and Teodoro del Ser. Their work appears in journals such as Pharmacological Research, European Journal of Endocrinology, Stroke, Digestive and Liver Disease and Peptides.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026